Live tape
Top 8, mentions 7d10,503TSLA2,131 mentions▲ +0.05GOOGL1,646 mentions▲ +0.04CRWV1,305 mentions▲ +0.03NVDA1,270 mentions▲ +0.07SPCX1,163 mentions▲ +0.07QQQ1,138 mentions▲ +0.05META941 mentions▲ +0.05NBIS909 mentions▲ +0.05

Equity · Healthcare

CYTK

NASDAQ

Cytokinetics, Incorporated

$81 −1.22% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 24, 2026
Price · Chart

This price chart is drawn by TradingView, from their own data, in an embed loaded from their servers. We hold too few licensed daily closes of our own for CYTK to draw a line in its place.

Track this symbol on TradingView TradingView chart · our licensed closes: 4 sessions, 21 Jul – 24 Jul 2026
Market cap $11.3B
52-week range $33.20 – $87.31
Avg volume 477.5K

as of Jul 24, 2026

CYTK insider trades

SEC Form 4 · last 90 days · newest reported trade 12 Oct 2026
Open-market buys 0
Open-market sells 17
Net sold $13.60M
Non-trade filings 14
Date Insider Type Shares Value
12 Oct 2026 Blum Robert I President & CEO Sell 7,500 $472K
06 Oct 2026 Malik Fady Ibraham EVP Research & Development Sell 3,500 $215K
28 Sep 2026 Blum Robert I President & CEO Sell 7,500 $491K
22 Sep 2026 Malik Fady Ibraham EVP Research & Development Sell 3,500 $239K
15 Sep 2026 Blum Robert I President & CEO Sell 97,926 $6.79M
15 Sep 2026 Landry Robert E Director Sell 1,000 $72K
14 Sep 2026 Blum Robert I President & CEO Sell 7,500 $551K
11 Sep 2026 Landry Robert E Director Sell 1,000 $75K
08 Sep 2026 Malik Fady Ibraham EVP Research & Development Sell 3,500 $264K
01 Sep 2026 PARSHALL B LYNNE Director Sell 5,000 $357K
31 Aug 2026 Blum Robert I President & CEO Sell 7,500 $527K
31 Aug 2026 Callos Andrew EVP, Chief Commercial Officer Sell 10,000 $702K

Showing the 12 most recent of 17 open-market trades in this window. The figures above count all of them.

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
12 Oct 2026 Blum Robert I President & CEO Option exercise 7,500 $80K
06 Oct 2026 Malik Fady Ibraham EVP Research & Development Option exercise 3,500 $27K
28 Sep 2026 Blum Robert I President & CEO Option exercise 7,500 $80K
22 Sep 2026 Malik Fady Ibraham EVP Research & Development Option exercise 3,500 $27K
14 Sep 2026 Blum Robert I President & CEO Option exercise 7,500 $80K
14 Sep 2026 Blum Robert I President & CEO Gift 99,276
08 Sep 2026 Malik Fady Ibraham EVP Research & Development Option exercise 3,500 $27K
31 Aug 2026 Blum Robert I President & CEO Option exercise 7,500 $80K
31 Aug 2026 Callos Andrew EVP, Chief Commercial Officer Option exercise 10,000 $233K
18 Aug 2026 Malik Fady Ibraham EVP Research & Development Option exercise 3,500 $27K
10 Aug 2026 Blum Robert I President & CEO Option exercise 7,500 $80K
30 Jul 2026 Callos Andrew EVP, Chief Commercial Officer Option exercise 14,000 $326K

Showing the 12 most recent of 14 compensation filings in this window. The figures above count all of them.

CYTK reported financials

SEC EDGAR XBRL SEC EDGAR

CYTK reported revenue of $88.0M for the fiscal year ended 31 Dec 2025. Net income over the same period was −$785.0M.

Figure Reported Period
Revenue $88.0M 31 Dec 2025 fiscal year
Net income −$785.0M 31 Dec 2025 fiscal year
Diluted EPS −$6.54 31 Dec 2025 fiscal year
Total assets $1.9B 30 Jun 2026 at period end
Total equity −$173.5M 30 Jun 2026 at period end

CYTK earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 −$1.50 —
31 Mar 2026 Q1 2026 −$1.67 —
31 Dec 2025 FY 2025 −$6.54 —
30 Sep 2025 Q3 2025 −$2.55 —
30 Jun 2025 Q2 2025 −$1.12 —
31 Mar 2025 Q1 2025 −$1.36 —
31 Dec 2024 FY 2024 −$5.26 —
30 Sep 2024 Q3 2024 −$1.36 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

CYTK institutional holders

SEC Form 13F SEC EDGAR

12 of the 45 institutional funds we track reported a CYTK position for the quarter ended 30 Jun 2026 — a combined $519.1M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
Point72 Asset Management Added +153.6% shares 1,587,712 $135.3M
D. E. Shaw & Co. Added +48.3% shares 1,048,103 $89.3M
Fisher Asset Management Held (±25%) −3.2% shares 743,697 $63.4M
Balyasny Asset Management Trimmed −28.3% shares 711,676 $60.6M
Citadel Advisors Trimmed −41.7% shares 640,945 $54.6M
Marshall Wace Trimmed −31.2% shares 451,467 $38.5M
Two Sigma Investments Held (±25%) +11.4% shares 317,411 $27.0M
Baker Bros. Advisors New position 211,267 $18.0M
AQR Capital Management Held (±25%) +3.4% shares 161,903 $13.8M
Millennium Management Held (±25%) +12.0% shares 109,717 $9.3M

Showing the 10 largest of 12 reported positions. The figures above count all of them.

CYTK fails-to-deliver

SEC CNS data SEC

On 30 Sep 2026, 2,845 shares of CYTK failed to deliver (about $187K).

Settlement date Shares failed Notional % of shares out
30 Sep 2026 2,845 $187K 0.002%
22 Sep 2026 94,823 $6.4M 0.068%
14 Sep 2026 98,000 $7.2M 0.070%

Congressional trades in CYTK

STOCK Act disclosures House disclosures

The most recent congressional trade disclosed in CYTK is a purchase by Gilbert Ray Cisneros, Jr. (house, CA), dated 29 Sep 2026.

Date Member Type Amount
29 Sep 2026 filed 12 Oct 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
30 Jun 2026 filed 02 Jul 2026 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
09 Oct 2025 filed 18 Nov 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
17 Jun 2025 filed 13 Aug 2025 Lisa C. McClain house · Republican–MI Sale $1K–$15K
11 Jun 2025 filed 13 Aug 2025 Lisa C. McClain house · Republican–MI Purchase $1K–$15K

Sources

  1. Finazonprior-day close, indicative (IEX-derived, not the official close)
  2. TradingViewthe price chart widget, drawn by TradingView from their own data
  3. SEC EDGARSEC EDGAR XBRL company facts · latest period ended 30 Jun 2026
  4. SEC EDGARSEC EDGAR 13F filings
  5. SECSEC fails-to-deliver (CNS) data
  6. House disclosuresU.S. House of Representatives financial disclosures
  7. SEC EDGARValuation computed from SEC EDGAR filings